Literature DB >> 27354424

Masked Hypertension and Cardiovascular Disease Events in a Prospective Cohort of Blacks: The Jackson Heart Study.

John N Booth1, Keith M Diaz1, Samantha R Seals1, Mario Sims1, Joseph Ravenell1, Paul Muntner1, Daichi Shimbo2.   

Abstract

Masked hypertension, defined as nonelevated clinic blood pressure (BP) with elevated out-of-clinic BP, has been associated with increased cardiovascular disease (CVD) risk in Europeans and Asians. Few data are available on masked hypertension and CVD and mortality risk among blacks. We analyzed data from the Jackson Heart Study, a prospective cohort study of blacks. Analyses included participants with clinic-measured systolic/diastolic BP <140/90 mm Hg who completed ambulatory BP monitoring after the baseline examination in 2000 to 2004 (n=738). Masked daytime (10:00 am-8:00 pm) hypertension was defined as mean ambulatory systolic/diastolic BP ≥135/85 mm Hg. Masked nighttime (midnight to 6:00 am) hypertension was defined as mean ambulatory systolic/diastolic BP ≥120/70 mm Hg. Masked 24-hour hypertension was defined as mean systolic/diastolic BP ≥130/80 mm Hg. CVD events (nonfatal/fatal stroke, nonfatal myocardial infarction, or fatal coronary heart disease) and deaths identified through December 2010 were adjudicated. Any masked hypertension (masked daytime, nighttime, or 24-hour hypertension) was present in 52.2% of participants; 28.2%, 48.2% and 31.7% had masked daytime, nighttime, and 24-hour hypertension, respectively. There were 51 CVD events and 44 deaths during a median follow-up of 8.2 and 8.5 years, respectively. CVD rates per 1000 person-years (95% confidence interval) in participants with and without any masked hypertension were 13.5 (9.9-18.4) and 3.9 (2.2-7.1), respectively. The multivariable adjusted hazard ratio (95% confidence interval) for CVD was 2.49 (1.26-4.93) for any masked hypertension and 2.86 (1.59-5.13), 2.35 (1.23-4.50), and 2.52 (1.39-4.58) for masked daytime, nighttime, and 24-hour hypertension, respectively. Masked hypertension was not associated with all-cause mortality. Masked hypertension is common and associated with increased risk for CVD events in blacks.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  African American; ambulatory blood pressure monitoring; black; blood pressure; cardiovascular disease; hypertension; masked hypertension

Mesh:

Year:  2016        PMID: 27354424      PMCID: PMC4945361          DOI: 10.1161/HYPERTENSIONAHA.116.07553

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  41 in total

1.  Laboratory, reading center, and coordinating center data management methods in the Jackson Heart Study.

Authors:  Myra A Carpenter; Richard Crow; Michael Steffes; William Rock; Jeffrey Heilbraun; Gregory Evans; Thomas Skelton; Robert Jensen; Daniel Sarpong
Journal:  Am J Med Sci       Date:  2004-09       Impact factor: 2.378

2.  Study design for genetic analysis in the Jackson Heart Study.

Authors:  James G Wilson; Charles N Rotimi; Lynette Ekunwe; Charmaine D M Royal; Mary E Crump; Sharon B Wyatt; Michael W Steffes; Adebowale Adeyemo; Jie Zhou; Herman A Taylor; Cashell Jaquish
Journal:  Ethn Dis       Date:  2005       Impact factor: 1.847

Review 3.  Ambulatory blood-pressure monitoring.

Authors:  Thomas G Pickering; Daichi Shimbo; Donald Haas
Journal:  N Engl J Med       Date:  2006-06-01       Impact factor: 91.245

4.  The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension.

Authors:  Daniel G Hackam; Robert R Quinn; Pietro Ravani; Doreen M Rabi; Kaberi Dasgupta; Stella S Daskalopoulou; Nadia A Khan; Robert J Herman; Simon L Bacon; Lyne Cloutier; Martin Dawes; Simon W Rabkin; Richard E Gilbert; Marcel Ruzicka; Donald W McKay; Tavis S Campbell; Steven Grover; George Honos; Ernesto L Schiffrin; Peter Bolli; Thomas W Wilson; Ross D Feldman; Patrice Lindsay; Michael D Hill; Mark Gelfer; Kevin D Burns; Michel Vallée; G V Ramesh Prasad; Marcel Lebel; Donna McLean; J Malcolm O Arnold; Gordon W Moe; Jonathan G Howlett; Jean-Martin Boulanger; Pierre Larochelle; Lawrence A Leiter; Charlotte Jones; Richard I Ogilvie; Vincent Woo; Janusz Kaczorowski; Luc Trudeau; Robert J Petrella; Alain Milot; James A Stone; Denis Drouin; Kim L Lavoie; Maxime Lamarre-Cliche; Marshall Godwin; Guy Tremblay; Pavel Hamet; George Fodor; S George Carruthers; George B Pylypchuk; Ellen Burgess; Richard Lewanczuk; George K Dresser; S Brian Penner; Robert A Hegele; Philip A McFarlane; Mukul Sharma; Debra J Reid; Sheldon W Tobe; Luc Poirier; Raj S Padwal
Journal:  Can J Cardiol       Date:  2013-03-29       Impact factor: 5.223

5.  Prognosis of "masked" hypertension and "white-coat" hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study.

Authors:  Takayoshi Ohkubo; Masahiro Kikuya; Hirohito Metoki; Kei Asayama; Taku Obara; Junichiro Hashimoto; Kazuhito Totsune; Haruhisa Hoshi; Hiroshi Satoh; Yutaka Imai
Journal:  J Am Coll Cardiol       Date:  2005-08-02       Impact factor: 24.094

6.  Cardiovascular disease event classification in the Jackson Heart Study: methods and procedures.

Authors:  Emmanuel Keku; Wayne Rosamond; Herman A Taylor; Robert Garrison; Sharon B Wyatt; Michelle Richard; Brenda Jenkins; Lisa Reeves; Daniel Sarpong
Journal:  Ethn Dis       Date:  2005       Impact factor: 1.847

7.  Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study.

Authors:  José Boggia; Yan Li; Lutgarde Thijs; Tine W Hansen; Masahiro Kikuya; Kristina Björklund-Bodegård; Tom Richart; Takayoshi Ohkubo; Tatiana Kuznetsova; Christian Torp-Pedersen; Lars Lind; Hans Ibsen; Yutaka Imai; Jiguang Wang; Edgardo Sandoya; Eoin O'Brien; Jan A Staessen
Journal:  Lancet       Date:  2007-10-06       Impact factor: 79.321

8.  STOP questionnaire: a tool to screen patients for obstructive sleep apnea.

Authors:  Frances Chung; Balaji Yegneswaran; Pu Liao; Sharon A Chung; Santhira Vairavanathan; Sazzadul Islam; Ali Khajehdehi; Colin M Shapiro
Journal:  Anesthesiology       Date:  2008-05       Impact factor: 7.892

Review 9.  The natural history of hypertension: prehypertension or masked hypertension?

Authors:  Thomas G Pickering
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-10       Impact factor: 3.738

10.  High prevalence of masked uncontrolled hypertension in people with treated hypertension.

Authors:  José R Banegas; Luis M Ruilope; Alejandro de la Sierra; Juan J de la Cruz; Manuel Gorostidi; Julián Segura; Nieves Martell; Juan García-Puig; John Deanfield; Bryan Williams
Journal:  Eur Heart J       Date:  2014-02-03       Impact factor: 29.983

View more
  29 in total

1.  Masked hypertension-what lies ahead?

Authors:  D E Anstey; D Shimbo
Journal:  J Hum Hypertens       Date:  2017-09       Impact factor: 3.012

2.  Prognostic Value of Masked Uncontrolled Hypertension.

Authors:  Sante D Pierdomenico; Anna M Pierdomenico; Francesca Coccina; Denis L Clement; Marc L De Buyzere; Dirk A De Bacquer; Iddo Z Ben-Dov; Wanpen Vongpatanasin; José R Banegas; Luis M Ruilope; Lutgarde Thijs; Jan A Staessen
Journal:  Hypertension       Date:  2018-10       Impact factor: 10.190

Review 3.  Blood Pressure Assessment in Adults in Clinical Practice and Clinic-Based Research: JACC Scientific Expert Panel.

Authors:  Paul Muntner; Paula T Einhorn; William C Cushman; Paul K Whelton; Natalie A Bello; Paul E Drawz; Beverly B Green; Daniel W Jones; Stephen P Juraschek; Karen L Margolis; Edgar R Miller; Ann Marie Navar; Yechiam Ostchega; Michael K Rakotz; Bernard Rosner; Joseph E Schwartz; Daichi Shimbo; George S Stergiou; Raymond R Townsend; Jeff D Williamson; Jackson T Wright; Lawrence J Appel
Journal:  J Am Coll Cardiol       Date:  2019-01-29       Impact factor: 24.094

Review 4.  Prevention and Control of Hypertension: JACC Health Promotion Series.

Authors:  Robert M Carey; Paul Muntner; Hayden B Bosworth; Paul K Whelton
Journal:  J Am Coll Cardiol       Date:  2018-09-11       Impact factor: 24.094

5.  Predicted Atherosclerotic Cardiovascular Disease Risk and Masked Hypertension Among Blacks in the Jackson Heart Study.

Authors:  D Edmund Anstey; John N Booth; Marwah Abdalla; Tanya M Spruill; Yuan-I Min; Paul Muntner; Daichi Shimbo
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2017-07

6.  Short-Term Reproducibility of Masked Hypertension Among Adults Without Office Hypertension.

Authors:  Laura P Cohen; Joseph E Schwartz; Daniel N Pugliese; D Edmund Anstey; Jessica P Christian; Stephanie Jou; Paul Muntner; Daichi Shimbo; Natalie A Bello
Journal:  Hypertension       Date:  2020-09-09       Impact factor: 10.190

7.  Association of Cardiovascular Outcomes With Masked Hypertension Defined by Home Blood Pressure Monitoring in a Japanese General Practice Population.

Authors:  Takeshi Fujiwara; Yuichiro Yano; Satoshi Hoshide; Hiroshi Kanegae; Kazuomi Kario
Journal:  JAMA Cardiol       Date:  2018-07-01       Impact factor: 14.676

8.  Cardiovascular Risk Factors and Masked Hypertension: The Jackson Heart Study.

Authors:  Samantha G Bromfield; Daichi Shimbo; John N Booth; Adolfo Correa; Gbenga Ogedegbe; April P Carson; Paul Muntner
Journal:  Hypertension       Date:  2016-10-24       Impact factor: 10.190

Review 9.  Hypertension in Blacks: Unanswered Questions and Future Directions for the JHS (Jackson Heart Study).

Authors:  Paul Muntner; Marwah Abdalla; Adolfo Correa; Michael Griswold; John E Hall; Daniel W Jones; George A Mensah; Mario Sims; Daichi Shimbo; Tanya M Spruill; Katherine L Tucker; Lawrence J Appel
Journal:  Hypertension       Date:  2017-03-20       Impact factor: 10.190

Review 10.  Research Needs to Improve Hypertension Treatment and Control in African Americans.

Authors:  Paul K Whelton; Paula T Einhorn; Paul Muntner; Lawrence J Appel; William C Cushman; Ana V Diez Roux; Keith C Ferdinand; Mahboob Rahman; Herman A Taylor; Jamy Ard; Donna K Arnett; Barry L Carter; Barry R Davis; Barry I Freedman; Lisa A Cooper; Richard Cooper; Patrice Desvigne-Nickens; Nara Gavini; Alan S Go; David J Hyman; Paul L Kimmel; Karen L Margolis; Edgar R Miller; Katherine T Mills; George A Mensah; Ann M Navar; Gbenga Ogedegbe; Michael K Rakotz; George Thomas; Jonathan N Tobin; Jackson T Wright; Sung Sug Sarah Yoon; Jeffrey A Cutler
Journal:  Hypertension       Date:  2016-09-12       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.